Risk corridor ruling could lead to $2.8 billion payout for insurers

A federal judge has ruled in favor of Oregon health insurer Moda Health in its lawsuit against the federal government over unpaid risk corridor payments included in the Affordable Care Act (ACA). The decision could open the floodgates for new insurer lawsuits to recoup some of the billions of dollars owed under the program.

Moda was one of several insurers to sue over the program, one of the mechanisms designed to shield ACA exchange insurers from losses in the first years of the new market.

Congress, however, said after the ACA was passed that the program had to be budget-neutral. with far more companies requesting money than paying into the program, the agency was only able to fulfill 12.6 percent of what insurers requested in its first year. The last update said the agency was still working through the backlog of unpaid requests from 2014.

While at least one similar lawsuit was tossed out of court, Judge Thomas Wheeler ruled that the program is not required to be budget-neutral and the government is liable for the withheld payments.

“The government made a promise in the risk corridors program that it has yet to fulfill,” Wheeler wrote in his ruling. “Today, the court directs the government to fulfill that promise. After all, to say to (Moda), 'The joke is on you. You shouldn't have trusted us,' is hardly worthy of our great government."

In Moda’s case, it would be owed $214 million for 2014 and 2015, with 2016 requests expected by the middle of this year. If CMS were compelled to pay the full amount insurers requested, it would be on the hook for nearly $2.8 billion just for 2014.

Wheeler’s ruling said CMS would have to make these payments as soon as possible. In rejecting many of the government’s arguments, he dismissed the claim that the government has discretion over the payment schedule, saying the ACA intended risk corridor payments to be made annually.

The next step in the case is a status hearing on March 1 where Wheeler expects to hear how both sides wish to proceed.

For the larger insurance industry, there’s no certainty payments will be coming anytime soon. Dawn Bonder, former CEO of Health Republic, the lead plaintiff in a separate risk corridor suit, welcomed the Moda ruling, but expected the Trump administration to appeal.

“It's great news, I'm very happy," Bonder said to The Oregonian. "But it's not over."

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.